Robert F. Kennedy Jr., as HHS Secretary, pledged federal support for psychiatric reform at a Mental Health and Overmedicalization Summit, challenging conventional practices and promising to address overprescribing. Kennedy acknowledged a role for psychiatric medications but emphasized they should not be the default treatment, reflecting growing skepticism about the pharmaceutical industry's influence in mental healthcare.

Psychiatry's medical model, adopted around 1980, framed mental conditions as brain diseases primarily treatable with pharmaceuticals. Despite the chemical imbalance theory never being substantiated, drugs like Prozac became marketed as miracle solutions. Today, one in six U.S. adults take antidepressants, yet research increasingly questions SSRI benefits while highlighting side effects like irreversible sexual dysfunction.

The reform movement includes figures like journalist Robert Whitaker, founder of Mad in America, and activist Laura Delano, who recounts devastating effects of psychiatric medications. This shift challenges psychiatry's reliance on the Diagnostic and Statistical Manual and questions whether normal human suffering has been over-pathologized, potentially reshaping multi-billion dollar pharmaceutical markets and treatment approaches.